Insider Transactions for Syndax Pharmaceuticals Inc (SNDX)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SNDXSyndax Pharmaceuticals IncGoldan Keith A.Chief Financial OfficerJul 31, 2023Option Exercise$18.1286215,6193,490Feb 09, 2024, 04:05 PM
SNDXSyndax Pharmaceuticals IncGoldan Keith A.Chief Financial OfficerJan 31, 2024Option Exercise$17.421,18320,6084,673Feb 09, 2024, 04:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorAug 09, 2023Option Exercise$13.52105,7101,428,94070,691Aug 10, 2023, 06:50 AM
SNDXSyndax Pharmaceuticals IncMeury WilliamDirectorAug 02, 2023Option Exercise$14.24166,0002,363,06083,000Aug 03, 2023, 09:12 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJul 10, 2023Option Exercise$14.58105,7101,541,60670,691Jul 11, 2023, 09:23 AM
SNDXSyndax Pharmaceuticals IncGoldan Keith A.Chief Financial OfficerJun 13, 2023Sale$22.3157712,8732,628Jun 14, 2023, 04:20 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJun 09, 2023Sale$14.42105,7101,524,20970,691Jun 09, 2023, 05:32 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorMay 09, 2023Option Exercise$13.89105,7101,468,69270,691May 10, 2023, 04:11 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorApr 10, 2023Option Exercise$12.95105,7101,369,45270,691Apr 12, 2023, 04:03 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DMar 13, 2023Option Exercise$14.45105,7081,527,88270,690Mar 14, 2023, 04:42 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerFeb 15, 2023Option Exercise$16.4050,000819,88317,428Feb 17, 2023, 06:09 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael AChief Executive OfficerFeb 06, 2023Option Exercise$17.0111,918202,71623,618Feb 08, 2023, 04:49 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DFeb 06, 2023Option Exercise$16.60105,7081,755,11870,690Feb 08, 2023, 04:49 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerJan 31, 2023Option Exercise$17.32691,19569Feb 03, 2023, 04:59 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerFeb 01, 2023Sale$28.43691,9620Feb 03, 2023, 04:59 PM
SNDXSyndax Pharmaceuticals IncLegault PierreDirectorJan 12, 2023Sale$18.1148,000869,06256,000Jan 13, 2023, 04:44 PM
SNDXSyndax Pharmaceuticals IncLegault PierreDirectorJan 13, 2023Sale$20.2930,000608,70042,000Jan 13, 2023, 04:44 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerDec 01, 2022Sale$15.6915,600244,7404,293Dec 02, 2022, 05:01 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerDec 02, 2022Sale$15.7234,400540,67217,465Dec 02, 2022, 05:01 PM
SNDXSyndax Pharmaceuticals IncKatkin KeithDirectorOct 06, 2022Option Exercise$17.0559,7981,019,58852,782Oct 07, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael AChief Executive OfficerOct 06, 2022Option Exercise$17.0332,462552,85433,890Oct 07, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael AChief Executive OfficerSep 30, 2022Sale$16.9059,2121,000,40247,265Oct 04, 2022, 05:49 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael AChief Executive OfficerOct 03, 2022Sale$16.895,76697,39120,542Oct 04, 2022, 05:49 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael AChief Executive OfficerOct 04, 2022Sale$16.902,56043,25218,939Oct 04, 2022, 05:49 PM
SNDXSyndax Pharmaceuticals IncKatkin KeithDirectorSep 30, 2022Option Exercise$16.577,122118,01734,914Oct 04, 2022, 05:49 PM
SNDXSyndax Pharmaceuticals IncKatkin KeithDirectorOct 03, 2022Option Exercise$16.483605,93232,167Oct 04, 2022, 05:49 PM
SNDXSyndax Pharmaceuticals IncKatkin KeithDirectorOct 04, 2022Option Exercise$16.7772012,07132,223Oct 04, 2022, 05:49 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 19, 2022Sale$16.96228,6783,879,339132,175Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 20, 2022Sale$17.08119,2982,037,18677,485Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 14, 2022Option Exercise$15.50175,2902,716,899105,481Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 15, 2022Option Exercise$15.70133,5502,096,81584,611Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 16, 2022Sale$15.99250,0003,998,66389,802Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncPodlesak DennisDirectorSep 15, 2022Sale$15.26133,6802,039,810142,603Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncPodlesak DennisDirectorSep 16, 2022Sale$14.8823,950356,48582,319Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerAug 24, 2022Option Exercise$15.6850,000783,95723,111Aug 26, 2022, 04:14 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerJul 29, 2022Option Exercise$14.122653,742265Aug 26, 2022, 04:14 PM
SNDXSyndax Pharmaceuticals IncLegault PierreDirectorAug 05, 2022Sale$16.1248,000773,70246,000Aug 09, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael AChief Executive OfficerJul 25, 2022Option Exercise$13.7263,204867,01437,423Jul 27, 2022, 06:42 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael AChief Executive OfficerJul 06, 2022Option Exercise$13.7330,018412,06532,668Jul 08, 2022, 05:51 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael AChief Executive OfficerJul 07, 2022Option Exercise$13.692002,73817,759Jul 08, 2022, 05:51 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 01, 2022Option Exercise$7.2070,545507,92488,381Apr 13, 2022, 04:09 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 04, 2022Option Exercise$7.203,12822,52220,964Apr 13, 2022, 04:09 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 01, 2022Option Exercise$14.76171,5902,532,45688,381Apr 05, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 04, 2022Option Exercise$14.606,25691,31520,964Apr 05, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerJan 31, 2022Option Exercise$12.391,41217,4951,412Feb 03, 2022, 05:32 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerFeb 01, 2022Sale$16.651,41223,5100Feb 03, 2022, 05:32 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerJan 31, 2022Option Exercise$12.391,71421,23623,280Feb 03, 2022, 05:31 PM
SNDXSyndax Pharmaceuticals IncNolte AlexanderChief Accounting OfficerJan 31, 2022Option Exercise$12.3996811,994968Feb 03, 2022, 05:31 PM
SNDXSyndax Pharmaceuticals IncNolte AlexanderChief Accounting OfficerFeb 01, 2022Sale$16.6596816,1170Feb 03, 2022, 05:31 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerDec 30, 2021Option Exercise$8.775,90051,74321,566Jan 03, 2022, 04:03 PM
SNDXSyndax Pharmaceuticals IncLegault PierreDirectorDec 20, 2021Sale$14.0540,000561,85036,000Dec 22, 2021, 06:25 PM
SNDXSyndax Pharmaceuticals IncLegault PierreDirectorDec 22, 2021Option Exercise$14.9448,000717,32640,000Dec 22, 2021, 06:25 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerDec 17, 2021Sale$15.4570,3121,086,32083,492Dec 20, 2021, 06:44 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COODec 16, 2021Sale$12.7345,430578,32240,374Dec 20, 2021, 06:44 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COODec 17, 2021Sale$12.703,35242,57019,335Dec 20, 2021, 06:44 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COODec 20, 2021Sale$14.22122,0001,734,29862,659Dec 20, 2021, 06:44 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COODec 13, 2021Option Exercise$12.7473,218932,76152,223Dec 15, 2021, 05:35 PM
SNDXSyndax Pharmaceuticals IncEgros FabriceDirectorNov 18, 2021Option Exercise$13.4828,060378,25030,000Nov 19, 2021, 04:06 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOOct 25, 2021Option Exercise$13.1789,4081,177,20462,363Oct 27, 2021, 04:11 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOOct 26, 2021Option Exercise$13.2032,592430,15633,955Oct 27, 2021, 04:11 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOSep 27, 2021Option Exercise$13.3648,874652,77842,096Sep 28, 2021, 04:36 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOSep 20, 2021Option Exercise$13.2262,910831,52249,114Sep 22, 2021, 04:50 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOSep 21, 2021Option Exercise$13.189,616126,72622,467Sep 22, 2021, 04:50 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOSep 22, 2021Option Exercise$13.116007,86617,959Sep 22, 2021, 04:50 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 17, 2021Sale$13.63140,5241,915,904118,598Sep 21, 2021, 04:35 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 20, 2021Sale$13.601001,36048,386Sep 21, 2021, 04:35 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOSep 13, 2021Sale$13.1133,302436,52634,310Sep 15, 2021, 04:16 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOSep 14, 2021Sale$13.1888,6981,168,70762,008Sep 15, 2021, 04:16 PM
SNDXSyndax Pharmaceuticals IncEgros FabriceDirectorAug 18, 2021Sale$11.8231,270369,53231,635Aug 20, 2021, 04:32 PM
SNDXSyndax Pharmaceuticals IncEgros FabriceDirectorMay 18, 2021Option Exercise$12.9727,218352,91329,609May 20, 2021, 04:46 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerApr 26, 2021Buy$15.465007,73015,666Apr 28, 2021, 04:15 PM
SNDXSyndax Pharmaceuticals IncPodlesak DennisDirectorApr 22, 2021Buy$14.1113,967197,07743,300Apr 22, 2021, 05:06 PM
SNDXSyndax Pharmaceuticals IncEgros FabriceDirectorMar 01, 2021Option Exercise$15.3320,482314,07426,241Mar 03, 2021, 04:16 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerFeb 08, 2021Option Exercise$13.8770,312975,52683,492Feb 10, 2021, 04:23 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerJan 31, 2021Option Exercise$12.001,77121,25248,336Feb 05, 2021, 04:21 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerJul 31, 2020Option Exercise$7.972,66521,24013,395Feb 05, 2021, 04:21 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerJan 31, 2021Option Exercise$12.001,77121,25215,166Feb 05, 2021, 04:21 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOFeb 01, 2021Sale$13.6930,000410,79932,659Feb 03, 2021, 05:53 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COODec 01, 2020Sale$15.0830,000452,51332,659Dec 03, 2020, 06:05 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerNov 23, 2020Sale$13.1259,944786,43529,972Nov 25, 2020, 04:38 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 09, 2020Sale$13.62125,8761,714,419109,503Nov 12, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 10, 2020Option Exercise$13.6334,932476,06764,031Nov 12, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COONov 04, 2020Sale$13.76200,0002,751,410117,659Nov 06, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncShea Richard PChief Financial OfficerJul 31, 2019Option Exercise$4.891,4016,8515,616Feb 14, 2020, 04:37 PM
SNDXSyndax Pharmaceuticals IncShea Richard PChief Financial OfficerJan 31, 2020Option Exercise$7.971,50511,9957,121Feb 14, 2020, 04:37 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerFeb 04, 2020Buy$8.0012,500100,00043,900Feb 05, 2020, 04:07 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerOct 10, 2019Buy$5.4011,00059,40031,400Oct 11, 2019, 06:33 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerMay 09, 2019Buy$7.5513,20099,72613,200May 13, 2019, 04:11 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerMay 13, 2019Buy$7.297,20052,51720,400May 13, 2019, 04:11 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerMar 21, 2019Buy$4.878397,230Mar 25, 2019, 04:03 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerMar 21, 2019Buy$4.921,1045,4367,222Mar 22, 2019, 04:05 PM
SNDXSyndax Pharmaceuticals IncShea Richard PChief Financial OfficerJan 31, 2019Option Exercise$4.762,52112,0004,215Feb 08, 2019, 04:27 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerJan 31, 2019Option Exercise$4.763,72017,7076,118Feb 08, 2019, 04:27 PM
SNDXSyndax Pharmaceuticals IncMetzger Michael APresident and COOJan 31, 2019Option Exercise$4.762,65912,6572,659Feb 08, 2019, 04:27 PM
SNDXSyndax Pharmaceuticals IncMeyers Michael L.SVP, Chief Medical OfficerOct 30, 2018Buy$4.792009582,398Nov 07, 2018, 04:02 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerApr 03, 2018Sale$9.0415,000135,6007,500Apr 03, 2018, 04:42 PM
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerMay 17, 2017Sale$13.485,73277,2555,000May 19, 2017, 11:27 AM
SNDXSyndax Pharmaceuticals IncROYSTON IVORDirectorMar 20, 2017Option Exercise$13.75125,0001,718,750625,545Mar 22, 2017, 01:37 PM
SNDXSyndax Pharmaceuticals IncROYSTON IVORDirectorMar 08, 2016Buy$12.00150,0001,800,000750,545Mar 08, 2016, 06:38 PM